Kopran Limited (NSE:KOPRAN)
125.00
+5.02 (4.18%)
Apr 6, 2026, 3:29 PM IST
Kopran Market Cap
Kopran has a market cap or net worth of 6.05 billion as of April 6, 2026. Its market cap has decreased by -23.51% in one year.
Market Cap
6.05B
Enterprise Value
7.24B
Revenue
6.20B
Ranking
n/a
PE Ratio
36.56
Stock Price
125.00
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 6.05B, an increase of 957.30%. That is a compound annual growth rate of 10.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 5.82B | -19.61% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.07T |
| Divi's Laboratories | 1.55T |
| Apollo Hospitals Enterprise | 1.06T |
| Cipla | 963.20B |
| Accent Microcell | 8.01B |
| Max India | 7.58B |
| Sigachi Industries | 7.39B |
| Remus Pharmaceuticals | 7.34B |